Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.25, Iss.3, 2011-06, pp. : 267-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D. Keating Gillian M. Wellington Keri

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite

A Guide to Drug Use During Percutaneous Coronary Intervention

By Choo J.K. Young J.J. Kereiakes D.J.

Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. : 2589-2601

Adis International

Access to resources Recommend Favorite

Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention?

By Doggrell Sheila

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1431-1433

Informa Healthcare

Access to resources Recommend Favorite

The Cost-Effectiveness of Fluvastatin in Hungary Following Successful Percutaneous Coronary Intervention

By Scuffham Paul Kósa József

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 4, 2006-08 ,pp. : 309-317

Springer Publishing Company

Access to resources Recommend Favorite

Evolving role of bivalirudin in percutaneous coronary interventions; impact of the REPLACE-2 study

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 1027-1033

Informa Healthcare

Access to resources Recommend Favorite